Literature DB >> 1735690

Cell cycle dependence of epidermal growth factor induced radiosensitization.

T T Kwok1, R M Sutherland.   

Abstract

The effect of epidermal growth factor on the radiation response of two human squamous carcinoma cell lines, A431 (from vulva) and SiHa (from cervix), was examined. In both lines, cells in S phase were more radioresistant than cells in other cell cycle phases. Epidermal growth factor present after irradiation enhanced the radiation response of A431 cells in different cell cycle phases, whereas no effect was seen for SiHa cells. The enhancement was maximum with 10 ng/ml epidermal growth factor and was associated mainly with a reduction in the shoulder region of the cell survival curve. The ratio between the n values of the control and epidermal growth factor treated total cell population, G1, S, and G2M cells is 2.2, 4.1, 1.7, and 2.2, respectively. Epidermal growth factor reduced plating efficiency by about 50% for A431 cells in different cell cycle phases whereas a slight increase in plating efficiency was seen for SiHa cells. The present results indicate that epidermal growth factor related radiosensitization is dependent on both cell line and cell cycle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735690     DOI: 10.1016/0360-3016(92)90867-h

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab.

Authors:  Jidong Hong; Yuping Peng; Yuping Liao; Wuzhong Jiang; Rui Wei; Lei Huo; Zaide Han; Chaojun Duan; Meizuo Zhong
Journal:  Exp Ther Med       Date:  2012-04-19       Impact factor: 2.447

Review 2.  Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors.

Authors:  Shao-Chun Wang; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

3.  Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells.

Authors:  Sarah E Golding; Rhiannon N Morgan; Bret R Adams; Amy J Hawkins; Lawrence F Povirk; Kristoffer Valerie
Journal:  Cancer Biol Ther       Date:  2009-04-22       Impact factor: 4.742

Review 4.  Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results.

Authors:  S M Huang; P M Harari
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.651

5.  Alteration of tumour response to radiation by interleukin-2 gene transfer.

Authors:  J Lee; J P Moran; B M Fenton; C J Koch; J G Frelinger; P C Keng; E M Lord
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

6.  Tumor Growth Suppression and Enhanced Radioresponse by an Exogenous Epidermal Growth Factor in Mouse Xenograft Models with A431 Cells.

Authors:  Yu Jin Lim; Sang-Rok Jeon; Jae Moon Koh; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2015-01-07       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.